News
Pricing Provides AmnioWrap2TM Reimbursement in All MAC Regions

14 December 2023

News
New York, December 13, 2023 - BioStem Technologies (OTC: BSEM) has announced the appointment of Thomas J. Dugan to the position of Chairman of the Board. Mr. Dugan brings a wealth of experience to the role, with proven, hands-on expertise as a senior executive who has ex...

13 December 2023

News
POMPANO BEACH, FLORIDA, December 13, 2023 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today annou...

13 December 2023

News
Installation expected to be Completed in Mid-2024

13 December 2023

News
NEW YORK, NY, December 11, 2023 - The FDA has cleared an Investigational New Drug Application (IND) for MyMD Pharmaceuticals (Nasdaq: MYMD) to initiate a  Phase 2 clinical trial of oral MYMD-1® as a treatment for rheumatoid arthritis (RA). The company plans to launch the...

11 December 2023

News
-Significant unmet need for regulated product in $2B US testing market--Opportunity for expedited pathway for kitted product in development-

6 December 2023

News
Upgrade of Gamma Knife® 4C with NEW Elekta ICON for most precise and accurate treatment of Intracranial cancers and other indications

28 November 2023

News
Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K. Rawal, Medical Director for Rajiv Gandhi Cancer Institute, performed complex Urology Oncology surgery, marking 500 surgery milestone using the SSi ...

27 November 2023

News
PRISM MediaWire

17 November 2023

News
NEW YORK, NY, November 14, 2023 - PRISM MediaWire - PRISM MarketView, a leader within the financial markets and news community, has debuted its PRISM Emerging Public Health Index.

14 November 2023

11
12
13
14
15
16
17
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.